Headlines

MSC2011 will be held August 22-24, 2011

Registration and Abstract Submission for MSC 2011: Innovations in Cell-Based Regenerative Therapies is now open--reserve your spot today!  MSC 2011, which will take place in Cleveland, OH, August 22-24, 2011, will offer a forum for the exchange and discussion of research, ideas, and cutting-edge breakthroughs in translational regenerative medicine. The breadth of topics from basic discovery through model validation, clinical product development, and therapeutic application, in addition to the links between academic and commercial labs, make this conference imperative for industrial researchers, academic investigators, IP and regulatory specialists, biotechnology development investors and post-doctoral and graduate students. 

News

Unable to access database. Please hit F5 on your keyboard to reload page.

Press Releases

Unable to access database. Please hit F5 on your keyboard to reload page.

Your email address:    
Cleveland skyline
Researcher Bios

The National Center for Regenerative Medicine brings together some of the nation’s foremost experts in the field of stem cell research and treatment. In addition the center’s education component enables nurses, graduate students, technicians, and physicians to acquire the complex skills required to perform groundbreaking research and deliver high quality patient care in this new field.

Approximately 110 researchers from Case Western Reserve University, Cleveland Clinic, and University Hospitals Case Medical Center are investigators in the center. Additional information about these researchers is available in the menu on this page.

What people are saying about the NCRM and its researchers

“This (center) will help us build on the solid foundation that we have developed for non-embryonic stem cell research in Cleveland,” said Ralph I. Horwitz, M.D., dean of the School of Medicine and director of the Case Research Institute. “It is a ringing endorsement of the research talent that is found at Case, the Cleveland Clinic and University Hospitals Case Medical Center.”

“There is clearly a synergy among Cleveland stem cell researchers that is being recognized at state and federal levels,” said Fred C. Rothstein, M.D., president and chief executive officer of University Hospitals Case Medical Center. “Over the last 30 years, the collaboration between UHCMC and Case has resulted in much deeper understanding of the potential for non-embryonic stem cells.”

“In addition to the state-of-the-art research that will impact the lives of countless people, this center fosters growing collaborations which will significantly contribute to Northeast Ohio’s continued emergence as a leading biomedical center,” said Paul DiCorleto, Ph.D., chair of The Lerner Research Institute at the Cleveland Clinic.